Optima Coil System OPTI0620COM18 (REF N/A)Recalls & reported problems
Balt USA LLC · The Optima Coil System is indicated for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations (AVMs) and arteriovenous fistulae. The Optima Coil System is also indicated for vascular occlusion of blood vessels within the neurovascular system to permanently obstruct blood flow to an aneurysm or other vascular malformation and for arterial and venous embolization in the peripheral vasculature. The Optima Coil System comprises of implant coil and a pusher assembly. The Optima Coil System is designed fr use with the XCEL Detachment Controller. The Optima coil is detached thermally with the XCEL Detachment Controller. · Class 2 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00818053026423), received between Jul 23, 2024 and Jul 23, 2024 — classified as 1 malfunction.
The most frequently reported specific device problem is “Premature Separation” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
3 other recalls cover devices cleared under the same FDA submission (K172390); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Recalls naming this device
- Jan 3, 2024Open, Classified
Discoloration was identified along the delivery pusher which was attributed to corrosion of the hypotube. The material which caused the corrosion was identified as remnants of solder flux residue remaining on the hypotube component of the delivery pusher. Due to the location of the delivery pusher within the delivery system, it is possible for the discoloration to mechanically break off from the delivery pusher, leaving the potential for the material to flow through the delivery system (i.e. microcatheter), and into the patient vasculature causing foreign emboli.
Z-1041-2024 · Root cause: Material/Component Contamination · FDA record ↗
Most reported problems
Device problems
- Premature Separation1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 23, 2024Premature Separation; Premature Separation
IT WAS REPORTED THAT: "IT WAS A CASE OF RUPTURED ACOM ANEURYSM HAVING TWO LOBES THE PHYSICAN PLANNED TO DO SIMPLE COILING.THE SUPPORT SYSTEM WAS NEURONMAX AND NAVIEN5F, THE HEADWAY 17 WAS PLACED INSIDE THE ANEURYSM WITH SUPPORT OF TRAXCESS14. HEADWAY 17 WAS CONNECTED WITH A FLUSH LINE. THE FIRST COIL OPTIMA 4*13 COMPLEX 10 SOFT WAS PREPARED AS PER IFU AND THEN ALIGNED TO THE HUB OF THE MICRO CATHETER .THE FIRST LOBE WAS COILED.THE SECOND COIL SIZE OF 5*17 OPTIMA COMPLEX10 SOFT WAS PREPARED AS PER IFU AND THEN ALIGNED TO THE HUB OF THE MICRO CATHETER .THE COIL WENT SMOOTHLY THROUGH THE SLEEVE INTO THE HUB OF HEADWAY 17 AND DURING COILING THE PHYSCIAN FELT RESISTANCE AND A GIVE AWAY FEEL SO HE DECIDED NOT TO CONTINUE WITH COIL AND RETRIEVED IT.THE COIL WAS PUSHED IN SALINE BOWL TO CHECK THE COIL , HE NOTICED THAT THE COIL WAS KIND OF STRECHED. HE DECIDED TO USE OPTIMA COMPLEX 18 6*20,IT WAS PREPARED AS PER IFU.THEN ALIGNED TO THE HUB OF THE MICRO CATHETER. THE COIL WENT SMOOTHLY THROUGH THE SLEEVE INTO THE HUB OF HEADWAY 17, AFTER TWO LOOPS OF THE COIL INSIDE THE ANEURYSM THE PHYSCIAN WAS PUSHING THE COIL BUT THE COIL WAS NOT MOVING LATER THE PHYSICIAN WAS RETERVING COIL BUT NO MOVEM
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19806284 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K172390. One submission often covers many models, so check the product and lot details in each record.
- Z-1988-2025 · May 8, 2025 · Open, ClassifiedOptima Coil System REFs/UDI-DI codes: OPTI0156BLK 00810068568875 OPTI0158BLK 00810068568882 OPTI0103BLK 00810068568851 OPTI0258BLK 00810068568929 OPTI0212BLK 00810068568912 OPTI020
- Z-0103-2023 · Sep 7, 2022 · Open, ClassifiedOptima Coil System Model Number OPTI0208CSS10, Model Number OPTI0308CSS10. Used in endovascular procedures.
- Z-1680-2022 · Jul 26, 2022 · Open, ClassifiedOptima Coil System Model OPTI0520CSF10. For endovascular embolization.
Other Device, Neurovascular Embolization devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page